Skip to main content
Log in

News from ESH

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Brodszky V, Kárpáti K, Májer I, Nagy V, Farsang C, Gulácsi L.Cost-effectiveness of indapamide monotherapy in stroke prevention in Hungary Journal of Hypertension 25 (Suppl. 2): 222, Jun 2007

  2. Lindgren P, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, Wedel H, Jönsson B.An amlodipine-based regimen is cost-effective compared to an atenolol-based regimen: results from the anglo-scandinavian cardiac outcomes trial Journal of Hypertension 25 (Suppl. 2): 137, Jun 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

News from ESH. Pharmacoecon. Outcomes News 533, 7 (2007). https://doi.org/10.1007/BF03296130

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03296130

Keywords

Navigation